Picture of cbdMD logo

YCBD cbdMD Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for cbdMD, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

2019
September 30th
2020
September 30th
2021
September 30th
2022
September 30th
2023
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-51.412.6-23.4-70.1-22.9
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items38.4-24.311.156.116.3
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.2431.7-1.93-2.770.57
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-15.4-10.7-14.1-15-4.3
Capital Expenditures-1.25-1.32-0.342-0.689-0.298
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.885-0.25-2.2101
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-2.13-1.57-2.55-0.6890.702
Financing Cash Flow Items-1.090.06200
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities17.922.428.2-4.04-1.32
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.40710.111.6-19.7-4.92